ArticleJournal of experimental & clinical cancer research : CR2022

Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma.

Hye Ri Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.